CATX

Perspective Therapeutics, Inc.

4.27

USD

CATX Earnings Reports

Positive Surprise Ratio

CATX beat 22 of 33 last estimates.

67%

Next Report

Date of Next Report

Apr 27, 2026

Estimate for Q1 26 (Revenue/ EPS)

$179.93K

-$0.38

Implied change from Q4 25 (Revenue/ EPS)

Implied change from Q1 25 (Revenue/ EPS)

-47.39%

+52.00%

Perspective Therapeutics, Inc. earnings per share and revenue

On Jan 20, 2026, CATX reported earnings of -- USD per share (EPS) for Q4 25, -- the estimate of -0.37 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 216.33 thousand, with a --% difference. The market reacted with a +11.81% price change (close before vs. close after earnings).

Looking ahead to Q1 26, 8 analysts forecast an EPS of -0.38 USD, with revenue projected to reach 179.93 thousand USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

FAQ

What were Perspective Therapeutics, Inc.'s earnings and revenue for the latest quarter Q4 2025?

For Q4 2025, Perspective Therapeutics, Inc. reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.

How did the market react to Perspective Therapeutics, Inc.'s Q4 2025 earnings?

The stock price moved up 11.81%, changed from $2.54 before the earnings release to $2.84 the day after.

When is Perspective Therapeutics, Inc. expected to report next?

The next earning report is scheduled for Apr 27, 2026.

What are the forecasts for Perspective Therapeutics, Inc.'s next earnings report?

Based on 8 analysts, Perspective Therapeutics, Inc. is expected to report EPS of -$0.38 and revenue of $179.93K for Q1 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.